NCT03678883 2026-04-039-ING-41 in Patients With Advanced CancersActuate Therapeutics Inc.Phase 2 Active not recruiting350 enrolled
NCT05864534 2025-10-03Phase 2a Immune Modulation With Ultrasound for Newly Diagnosed GlioblastomaNorthwestern UniversityPhase 2 Recruiting25 enrolled